Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1148/radiol.2411040165
This Article
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Michel, S. J.
Right arrow Articles by Given, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Michel, S. J.
Right arrow Articles by Given, C. A., II
(Radiology 2006;241:310-324.)
© RSNA, 2006


Diagnosis Please

Case 99: Canavan Disease1

Steven J. Michel, MD and Curtis A. Given, II, MD

1 From the Department of Diagnostic Radiology, University of Kentucky Chandler Medical Center, Lexington, Ky. Received January 28, 2004; revision requested April 12; revision received May 13; accepted May 24; final version accepted July 26.

Correspondence: Address correspondence to S.J.M., Northwest Radiologists, 2930 Squalicum Pkwy, Suite 101, Bellingham, WA 98225 (email: s_j_michel{at}yahoo.com).


    HISTORY
 TOP
 HISTORY
 IMAGING FINDINGS
 DISCUSSION
 References
 
A 21-month-old boy, born without complications after an uncomplicated pregnancy, failed to achieve expected developmental milestones. As an infant, he developed nystagmus and poor muscular head control. Physical examination findings were notable for generalized hypotonia and macrocephaly. Magnetic resonance (MR) imaging and single-voxel MR spectroscopy were performed.


    IMAGING FINDINGS
 TOP
 HISTORY
 IMAGING FINDINGS
 DISCUSSION
 References
 
There was diffuse, bilateral, and symmetric increased T2 signal intensity throughout the cerebral white matter (Figs 13). These findings were noted to a lesser degree in the cerebellar white matter, thalamus, globi pallidi, and dorsal brainstem (Figs 1, 2). The white matter abnormality specifically involved the subcortical white matter. There was no lobar predominance of white matter abnormalities. Hydrocephalus, mass effect, and midline shift were absent. Single-voxel point-resolved spatially localized MR spectroscopy was performed for localization within the right parietal periventricular white matter and revealed a marked increase in both the N-acetylaspartate (NAA) peak and the ratio of NAA to creatinine (Fig 4). The choline peak was not elevated.


Figure 1
View larger version (118K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1: Transverse T2-weighted (repetition time msec/echo time msec, 4900/105) MR image of the brain obtained through the posterior fossa demonstrates extensive signal hyperintensity of temporal lobe white matter with relative sparing of cerebellar white matter.

 

Figure 2
View larger version (118K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2: Transverse T2-weighted (4900/105) MR image of the brain obtained through the basal ganglia demonstrates bilateral symmetric white matter hyperintensity.

 

Figure 3
View larger version (133K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 3: Transverse T2-weighted (4900/105) MR image of the brain obtained through the centrum semiovale shows bilaterally symmetric increased signal intensity within cerebral white matter with involvement of subcortical arcuate fibers (arrow).

 

Figure 4
View larger version (34K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 4: Single-voxel MR spectroscopic image of right parietal white matter reveals markedly elevated NAA peak. Spectrum shows ratios of NAA to creatine (Cr) (4.41) and NAA to choline (Cho) (7.54). Cr2 = methylene protons of creatine. The choline and creatinine peaks are within normal limits.

 

    DISCUSSION
 TOP
 HISTORY
 IMAGING FINDINGS
 DISCUSSION
 References
 
Differential diagnostic considerations based on imaging findings include dysmyelinating diseases such as metachromatic leukodystrophy, adrenoleukodystrophy, Pelizaeus-Merzbacher disease (PMD), Alexander disease, and Canavan disease. Metachromatic leukodystrophy causes bilateral symmetric white matter hyperintensity on T2-weighted MR images; however, this disease spares the subcortical white matter. The subcortical white matter was not spared in this patient. Adrenoleukodystrophy leads to bilateral symmetric T2 hyperintensity within the cerebral white matter. As with metachromatic leukodystrophy, the subcortical white matter fibers are classically spared. Additionally, adrenoleukodystrophy tends to progress in an orderly fashion from one portion of the brain to the next with an advancing edge of contrast enhancement.

PMD demonstrates bilateral symmetric white matter T2 hyperintensity with involvement of the subcortical arcuate fibers. However, patients with PMD may also have marked cerebellar atrophy and progressive enlargement of cortical sulci; these findings were not seen in this patient (1). Patients with PMD do not present with macrocephaly, and MR spectroscopy has revealed normal NAA and creatinine levels (2).

Canavan disease demonstrates bilateral symmetric T2 white matter hyperintensity, including involvement of the subcortical arcuate fibers. This disease appears diffusely throughout the cerebral white matter, does not enhance at computed tomography (CT) or MR imaging, and demonstrates variable involvement of the basal ganglia and cerebellar white matter (35). Patients with Alexander disease present with clinical and imaging findings similar to those of patients with Canavan disease; this condition often results in a clinical conundrum. For example, both Canavan disease and Alexander disease demonstrate macrocephaly with bilaterally symmetric increased T2 signal intensity of cerebral white matter and involvement of subcortical arcuate fibers.

Historically, Canavan disease has been differentiated from Alexander disease by means of brain biopsy (6). MR spectroscopy, however, has been shown to be a useful diagnostic tool in making this distinction. There is an accumulation of NAA in patients with Canavan disease because of a deficiency in the myelin synthesis pathway; thus, MR spectroscopy reveals a markedly elevated NAA peak. Alexander disease has not demonstrated elevation of the NAA peak in clinical cases because of the defect in glial fibrillary acidic protein, and it is pathologically characterized by widespread Rosenthal fibers (79). The combination of the T2 signal hyperintensity in the white matter and the markedly elevated NAA level on MR spectroscopic images allowed Canavan disease to be diagnosed in this patient (10). Our imaging findings were clinically confirmed by elevated urine NAA levels and identification of a gene mutation within the aspartoacylase enzyme at polymerase chain reaction assay.

Canavan disease, or spongiform degeneration of cerebral white matter, is an autosomal recessive dysmyelinating disease believed to result from a deficiency of aspartoacylase, which is a key enzyme in the myelin synthesis pathway (11). This deficiency leads to an abnormal accumulation of NAA in the serum and urine. Patients present with spasticity and macrocephaly within the 1st year of life, as did our patient; poor muscular head control and blindness are additional findings (12). Death usually occurs within the first few years of life, although a more protracted course has been reported (13). Canavan disease is characterized pathologically by vacuolization of subcortical white matter tracts throughout the cerebrum and, to a lesser extent, the cerebellum (14). Cortical gray matter injury occurs in a similar fashion but with less ferocity. CT findings include diffuse decreased attenuation of subcortical white matter without contrast enhancement. MR imaging demonstrates diffuse, bilateral, and symmetric increased T2 signal intensity of cerebral subcortical white matter (3). Involvement of the basal ganglia was present to some degree in this patient and has been variably noted in the literature (35). Several investigators have shown the markedly elevated NAA peak on MR spectroscopic images in patients with Canavan disease (11,15). There is also an increase in the NAA-to-choline ratio and the NAA-to-creatinine ratio; these findings are considered indicative of Canavan disease given the associated white matter abnormalities.


    FOOTNOTES
 

Part one of this case appeared 4 months previously and may contain larger images.

 


    References
 TOP
 HISTORY
 IMAGING FINDINGS
 DISCUSSION
 References
 

  1. Cheon JE, Kim IO, Hwang YS, et al. Leukodystrophy in children: a pictorial review of MR imaging features. RadioGraphics 2002;22:461–476.[Abstract/Free Full Text]
  2. Takanashi J, Sugita K, Osaka H, Ishii M, Niimi H. Proton MR spectroscopy in Pelizaeus-Merzbacher disease. AJNR Am J Neuroradiol 1997;18:533–535.[Abstract]
  3. McAdams HP, Geyer CA, Done SL, Deigh D, Mitchell M, Ghaed VN. CT and MR imaging of Canavan disease. AJNR Am J Neuroradiol 1990;11:397–399.[Medline]
  4. Rushton AR, Shaywitz BA, Duncan CC, Geehr RB, Manuelidis EE. Computed tomography in the diagnosis of Canavan's disease. Ann Neurol 1981;10:57–60.[CrossRef][Medline]
  5. Andriola MR. Computed tomography in the diagnosis of Canavan's disease. Ann Neurol 1982;11:323–324.[CrossRef][Medline]
  6. MacGregor DL, Humphrey RP, Armstrong DL, Becker LE. Brain biopsies for neurodegenerative disease in children. J Pediatr 1978;92:903–905.[CrossRef][Medline]
  7. Imamura A, Orii KE, Mizuno S, Hoshi H, Kondo T. MR imaging and 1H-MR spectroscopy in a case of juvenile Alexander disease. Brain Dev 2002;24:723–726.[CrossRef][Medline]
  8. Brockmann K, Dechent P, Meins M, et al. Cerebral proton magnetic resonance spectroscopy in infantile Alexander disease. J Neurol 2003;250:300–306.[CrossRef][Medline]
  9. Johnson AB, Brenner M. Alexander's disease: clinical, pathologic, and genetic features. J Child Neurol 2003;18(9):625–632.[Abstract/Free Full Text]
  10. Barkovich AJ. Pediatric neuroimaging. New York, NY: Raven, 2000; 117.
  11. Wittsack HJ, Kugel H, Roth B, Heindel W. Quantitative measurements with localized 1H MR spectroscopy in children with Canavan's disease. J Magn Reson Imaging 1996;6:889–893.[Medline]
  12. Gordon N. Canavan disease: a review of recent developments. Eur J Paediatr Neurol 2001;5:65–69.[CrossRef][Medline]
  13. Zafeiriou DI, Kleijer WJ, Maroupoulos G, et al. Protracted course of N-acetylaspartic aciduria in two non-Jewish siblings: identical clinical and magnetic resonance imaging findings. Brain Dev 1999;21:205–208.[CrossRef][Medline]
  14. Gambetti P, Mellman WJ, Gonatas NK. Familial spongy degeneration of the central nervous system (Van Bogaert-Bertrand disease): an ultrastructural study. Acta Neuropathol (Berl) 1969;12:103–115.[CrossRef][Medline]
  15. Grodd W, Krageloh-Mann I, Klose U, Sauter R. Metabolic and destructive brain disorders in children: findings with localized proton MR spectroscopy. Radiology 1991;181(1):173–181.[Abstract/Free Full Text]
Congratulations to the 239 individuals and eight resident groups that submitted the most likely diagnosis (Canavan disease) for Diagnosis Please, Case 99. The names and locations of the individuals and resident groups, as submitted, are as follows:

Individual responses

Hisashi Abe, MD, Osaka, Japan
Gholamali Afshang, MD, Tinley Park, Ill
Jorge Ahualli, San Miguel de Tucumán, Tucumán, Argentina
Dr Erhan Akpinar, Ankara, Turkey
Canan Altay, MD, Balcova, Izmir, Turkey
Albert J. Alter, Madison, Wis
A. Anbarasu, MD, FRCR, Coventry, United Kingdom
Rajeev Anugu, MD, Bryn Mawr, Pa
Giovanni Maria Argiolas, MD, Cagliari, Italy
Manohar Aribandi, MD, Danville, Pa
Lionel Arrivé, Paris, France
Aaron Scott Bailey, MD, San Antonio, Tex
Ken Baliga, Rockford, Ill
Gregory J. Balmforth, MD, Tucson, Ariz
Arivalagan Bapusamy, Newcastle upon Tyne, United Kingdom
Sebastian Bazzano, MD, PhD, Rancagua, Chile
Rich Benedikt, MD, San Antonio, Tex
Sanjay Bhat, Temple, Tex
Gustav Blomquist IV, Houston, Tex
Dr Adrian Brady, FFRRCSI, Cork, Ireland
Steve Breiter, MD, Baltimore, Md
Eric L. Bressler, MD, Minnetonka, Minn
Daniel F. Broderick, MD, Jacksonville, Fla
Ghislain Brousseau, MD, Charlesbourg, Quebec, Canada
Douglas C. Brown, MD, Virginia Beach, Va
Michael P. Buetow, MD, Okemos, Mich
Peter C. Buetow, MD, Bellingham, Wash
Dr Marcelo F. Cabrini, Buenos Aires, Argentina
Özgür Çkmak, MD, Antalya, Turkey
Marc A. Camacho, MD, MS, Richmond, Va
Martín Campi, Godoy Cruz, Mendoza, Argentina
Dairong Cao, Fuzhou, Fujian, China
Carlos Capiel, Jr, MD, Mar del Plata, Buenos Aires, Argentina
Dr Carlos R. Castillo, Buenos Aires, Argentina
Paloma Cebrián Villar, Salamanca, Spain
Luisa F. Cervantes, Miami, Fla
Alan Dong Shing Chan, MD, West Sacramento, Calif
Govind Chavhan, MD, Toronto, Ontario, Canada
Bang-Bin Chen, MD, Taipei, Taiwan
Dra Marina Chiesa, Córdoba, Argentina
Dr Dinesh Chinchure, Hyderabad, India
Haris Chrysikopoulos, MD, Kerkyra, Greece
Dr Christopher Chu, Cabarita, New South Wales, Australia
Neal R. Conti, MD, Seattle, Wash
Peter Corr, Al Ain, United Arab Emirates
Alberto Cuñat, Valencia, Spain
Marco Antonio Cura, MD, San Antonio, Tex
Anil Kumar Dasyam, Pittsburgh, Pa
Wayne L. Davis, MD, Missoula, Mont
Marc G. de Baets, MD, Lugano, Switzerland
Peter C. De Baets, MD, Damme, Belgium
Helder de Castro Marques, MD, Juiz de Fora, Minas Gerais, Brazil
José Luiz F. De Mendonca, MD, Brasilia, Brazil
Wagner Diniz de Paula, MD, Brasilia, Brazil
Jon De Witte, Bishop, Ga
Seena Dehkharghani, MD, Phoenix, Ariz
Mustafa Kemal Demir, MD, Ataköy, Istanbul, Turkey
Thaworn Dendumrongsup, MD, Hat, Yai, Songkla, Thailand
Nam Ky Do, Duluth, Ga
Arthur B. Dublin, MD, MBA, FACR, Sacramento, Calif
Michael D. Edwards, MD, Oak Ridge, Tenn
Seyed Emamian, MD, PhD, Rockville, Md
Volkher Engelbrecht, MD, PhD, Amberg, Germany
Juliet H. Fallah, MD, Chicago, Ill
Shella Farooki, MD, Dublin, Ohio
Laura Z. Fenton, MD, Denver, Colo
Geoffrey L. Fey, MD, Richmond, Va
Ricardo Fonseca, MD, Nashville, Tenn
Akira Fujikawa, Tokyo, Japan
Dr Ram Prakash Galwa, Chandigarh, India
Douglas Gardner, MD, Windsor, Ontario, Canada
William Gawman, MD, Waterloo, Ontario, Canada
Fouad Gellad, MD, Timonium, Md
Gilles Genin, MD, Annecy, France
Dietrich Gerhardt, MD, Bettendorf, Iowa
Moshe Goldfeld, Nahariya, Israel
Mark G. Goldshein, MD, Andover, Mass
Eduardo Gonzalez Toledo, MD, PhD, Shreveport, La
Francisco J. Gonzalez, MD, Cantabria, Spain
José Dilermando Gotardo, São Paulo, Brazil
Sadashiva Gowda, Jr, MD, Davangere, Karnataka, India
James Wagter Graham, MD, Landstuhl, Germany
Dan Gridley, Phoenix, Ariz
D. Joseph Grunz, MD, Ladue, Mo
Flavius Guglielmo, MD, Basking Ridge, NJ
Preeti Gupta, MD, Worcester, Mass
Horacio Gutierrez, MD, Longmont, Colo
Jeffrey Haithcock, MD, Irving, Tex
Ferris M. Hall, MD, Boston, Mass
Srinivasan Harish, Hamilton, Ontario, Canada
Andreas Harzheim, MD, Cologne, Germany
Soichiro Hase, Niihama, Japan
D. Cressler Heasley, Jr, MD, Dallas, Tex
Raúl Hernández, Madrid, Spain
Helen T. Ho, MD, Chicago, Ill
Lowrey H. Holthaus, MD, Richmond, Va
Ronald J. Homer, MD, Weston, Conn
Suzanne Homer, MD, Weston, Conn
Alberto Iaia, MD, Wilmington, Del
Waleed Ibrahim, MD, Detroit, Mich
Rajapandian Ilangovan, MD, FRCR, London, United Kingdom
Kiriakos Kalampoukas, MD, Athens, Greece
Tomy Paul Kalapparambath, Troy, Mich
Sangam Kanekar, MD, Hershey, Pa
Kamil Karaali, MD, Antalya, Turkey
Katsuhiko Kato, MD, PhD, Nagoya, Japan
Nurettin Katranci, MD, Antalya, Turkey
Abdul-Majid Khan, MD, Bloomfield Hills, Mich
John C. Kirkham, MD, Richmond, Va
Jacobo Kirsch, MD, Cleveland, Ohio
Takuji Kiryu, MD, PhD, Gifu, Japan
Steven A. Klein, MD, Shrewsbury, Mass
Mehmet Kocak, MD, Milwaukee, Wis
Masamichi Koyama, Tokyo, Japan
Dr Mahesh Kumar, Greater Manchester, United Kingdom
Mark Kutler, MD, Dallas, Tex
Stefanos Lachanis, MD, Athens, Greece
Mario Laguna, West Allis, Wis
Douglas R. Lake, Charleston, SC
Matias Landi, Mar del Plata, Buenos Aires, Argentina
Michael Laucella, MD, Bayshore, NY
Dr Martin Lecompte, Ottawa, Ontario, Canada
John T. Lim, MD, Newport Coast, Calif
David A. Lisle, Brisbane, Australia
Pablo Longhi Lorenzzoni, Porto Alegre, Brazil
Patricia Lowry, MD, Richmond, Va
Marina Lucchesi, Junin, Buenos Aires, Argentina
Franklin Marden, MD, Fairfax, Va
Paulo Mariz Filho, MD, Salvador, Buenos Aires, Brazil
Michael B. Martin, MD, Austin, Tex
Fernando Mas-Estelles, Valencia, Spain
John A. Mattingly, MD, Belleville, Ill
Waldir Maymone, Rio de Janeiro, Brazil
Walter P. Maynard, MD, Inglewood, Calif
Frank McKowne, MD, Vancouver, Wash
Rogério Melo, Belo Horizonte, Brazil
Koen Pieter Mermuys, MD, Heverlee, Belgium
Nikolaos Michailidis, MD, Thessaloniki, Greece
Juan A. Millan, MD, Seattle, Wash
Manabu Minami, MD, Tsukuba, Ibaraki, Japan
Mansour Mirfakhraee, MD, Shreveport, La
Robert L. Mittl, Jr, MD, Charlotte, NC
Sankar Ranjan Mondal, MD, Nassau, Bahamas
Eduardo Mondello, MD, Buenos Aires, Argentina
Gregg E. Moral, MD, Cedarburg, Wis
Dr Subramaniyam Murugan, Ramnagar, Coimbatore, India
Mahesh Kumar Neelala Anand, FRCR, Greater Manchester, United Kingdom
Tammam Naim Nehme, MD, East Wenatchee, Wash
Honorio Chiminazzo Neto, Campinas, São Paulo, Brazil
Mizuki Nishino, MD, Boston, Mass
Albert Nizzero, MD, Sudbury, Ontario, Canada
Hiroshi Nobusawa, MD, Tokyo, Japan
Ingo Nölte, Mannheim, Germany
Patrick O'Keeffe, Boston, Mass
Laura Oleaga, MD, Bilbao, Spain
Michael Opatowsky, MD, Dallas, Tex
Sanford M. Ornstein, MD, Phoenix, Ariz
Dr Klaus Orth, Aachen, Germany
Carlos Ovejero Vela, MD, Barcelona, Spain
Ann Burleson Owen, MD, Murfreesboro, Tenn
Dr Deepak M. Pai, Newcastle upon Tyne, United Kingdom
Neeraj J. Panchal, MD, San Diego, Calif
Harish Panicker, MD, Hermitage, Pa
Narendrakumar P. Patel, MD, Newburgh, NY
Prakash N. Patel, MD, New City, NY
Ernesto Oscar Pearson, MD, Besançon, France
Yeliz Pekcevik, Izmir, Turkey
Javier Perich, Barcelona, Spain
John M. Plotke, MD, Naperville, Ill
Sanjay P. Prabhu, MBBS, Melbourne, Australia
Henry F. W. Pribram, MD, Laguna Beach, Calif
Prashant Raghavan, MD, Charlottesville, Va
Karthikram Raghuram, Birmingham, Ala
Anuradha T. Rao, Houston, Tex
Enrique Remartinez Escobar, MD, Melilla, Spain
Matthew C. Rheinboldt, MD, Nashville, Tenn
Mathieu Rodallec, Paris, France
Scott J. Rowen, MD, Orange, Calif
Stuart A. Royal, MS, MD, Birmingham, Ala
Hedieh Saghari, MD, Phoenix, Ariz
Guis Saint-Martin Astacio, MD, Leblon, Rio de Janeiro, Brazil
Tsutomu Sakamoto, MD, Tokyo, Japan
Gustavo Santos de Souza, MD, Brasilia, Brazil
Dr Robert Sauer, St Pölten, Austria
Steven Schepers, MD, Herent, Belgium
Janet Scheraga, Syracuse, NY
Steven M. Schultz, MD, Fort Worth, Tex
Joel M. Schwartz, MD, New City, NY
Simona Secci, MD, Cagliari, Italy
Dra Mariela Alejandra Severi, Córdoba, Argentina
Dr A. Krishna Prasad Shanbhogue, Chandigarh, India
Matt Shapiro, MD, Charlottesville, Va
Hideki Shima, MD, Tokyo, Japan
Taro Shimono, MD, Osaka, Japan
David F. Sobel, MD, La Jolla, Calif
Gustavo Socolsky, MD, Tucamán, Argentina
James D. Sprinkle, Jr, MD, Spotsylvania, Va
Anouk Stein, MD, Phoenix, Ariz
Scott Stevens, MD, Cincinnati, Ohio
Kouichi Sugiyama, Numazu, Japan
Vinod Sukumaran II, MD, Trivandrum, India
Venkateswar Rao Surabhi, Herndon, Va
Amit Suri, MD, DNB, Norfolk, United Kingdom
Norio Takahashi, MD, Fukui, Japan
Eliko Tanaka, MD, Yokohama, Japan
Toyohiko Tanaka, MD, Otsu, Shiga, Japan
Weawdao Techawattanakul, MD, Chiengrai, Thailand
Douglas L. Teich, MD, Brookline, Mass
Rogério Teles de Melo, Belo Horizonte, Brazil
Kazuma Terauchi, Fujieda, Shizuoka, Japan
Khin Khin Tha, MBBS, PhD, Sapporo, Japan
Eugene Tong, MD, Austin, Tex
Hüseyin Gürkan Töre, MD, Ankara, Turkey
William C. Torreggiani, MB, Dublin, Ireland
Dr Özgür Tosun, Bilkent, Ankara, Turkey
Unni Udayasankar, MD, FRCR, Atlanta, Ga
Hiroyuki Ueda, Kyoto, Japan
Eleni Vafeiadou, Thessaloniki, Greece
Ricardo Vallejos, San Isidro, Buenos Aires, Argentina
Piet Vanhoenacker, MD, Moorsel, Belgium
Alexander Vidershayn, Brooklyn, NY
Julio Vietti, Buenos Aires, Argentina
Christopher P. Vittore, MD, Rockford, Ill
Jesús Ig. Vivancos, MD, Tenerife, Spain
Dr Silvio Vollmer, Cipolleti, Rio Negro, Argentina
Nicolaus A. Wagner-Bartak, MD, Houston, Tex
Peter Waibel, MD, St Gallen, Switzerland
Steven T. Welch, MD, Kansas City, Mo
Christopher Wen, MD, Long Beach, Calif
Joseph R. Whitnah, MD, Mercer Island, Wash
David Wilkes, MD, Dallas, Tex
Edward Williams, Isle of Man, United Kingdom
Scott R. Wottrich, MD, Atlanta, Ga
Kei Yamada, Kyoto, Japan
Ensar Yekeler, MD, Istanbul, Turkey
Stanko Yovichevich, MD, Sydney, Australia
Joe Yut, Olathe, Kan
Thomas T. Zacharia, MD, New York, NY
Yu Zhang, San Francisco, Calif

Resident group responses

Baylor University Medical Center-Dallas Radiology Residents, Dallas, Tex
Clinica Radiologica Luiz Felippe Mattoso Radiology Residents, Rio de Janeiro, Brazil
Diagnóstico Maipú Radiology Residents, Vicente Lopez, Buenos Aires, Argentina
Hospital Italiano de Córdoba Radiology Residents, Córdoba, Argentina
Kyoto City Hospital Radiology Residents, Kyoto, Japan
Prince of Songkla University Radiology Residents, Hat Yai, Songlka, Thailand
Trakya University Radiology Residents, Edirne, Turkey
University of Pennsylvania Radiology Residents, Philadelphia, Pa





This Article
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Michel, S. J.
Right arrow Articles by Given, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Michel, S. J.
Right arrow Articles by Given, C. A., II


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE